The use of predicted SARS-CoV-2 class I epitopes of optimal size can also underestimate the level of virus-specific CD8+ T cells in COVID-19 convalescents due to the limitations in epitope-predicting algorithms, especially for CD4+ T cells [16]. This evidence concerns the gene CD4 and COVID-19.